SynAct Pharma AB

SynAct Pharma AB

Description

biotechnology company aiming to develop new medicine for the treatment of inflammatory diseases

SynAct Pharma AB

Address

Scheelevägen 2, c/o Medicon Village AB, 22361 Lund
Lund, Sweden

Contact

investor.relations@synactpharma.com

Description

biotechnology company aiming to develop new medicine for the treatment of inflammatory diseases

Matchmaking

Connect with SynAct Pharma AB

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways